TWA
INBX

TCI Wealth Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

TCI Wealth Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-105
Closed -$5K – 2602
2021
Q4 		$5K Hold
105
– – ﹤0.01% 1762
2021
Q3 		$3K Buy
+105
New +$3.19K ﹤0.01% 2085

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

TCI Wealth Advisors's INBX Position: Q1 2022 in Review

TCI Wealth Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2022, closing a stake of 105 shares — an estimated $5K sold.

TCI Wealth Advisors first reported a position in INBX in Q3 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 99 funds tracked by Wall St. Rank hold INBX as of Q1 2022.

  • TCI Wealth Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 105 Inhibrx, Inc. Common Stock shares in Q1 2022, an estimated $5K.
  • TCI Wealth Advisors first reported a position in Inhibrx, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • TCI Wealth Advisors's Inhibrx, Inc. Common Stock position peaked at $5K in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.